• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二氢杨梅素在神经疾病中的药理机制及潜在临床应用

Pharmacological mechanisms and potential clinical applications of Dihydromyricetin in neurological disorders.

作者信息

Zhang Yike, Zhang Tingting, Zhao Manli, Li Peichun, Liu Tao, Xie Jiangbo

机构信息

Clinical Integration of Traditional Chinese and Western Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.

Department of Neurology, Weifang Traditional Chinese Hospital, Weifang, China.

出版信息

Front Pharmacol. 2025 Jul 16;16:1618623. doi: 10.3389/fphar.2025.1618623. eCollection 2025.

DOI:10.3389/fphar.2025.1618623
PMID:40740995
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12308142/
Abstract

Neurological disorders (e.g., Alzheimer's disease, Parkinson's disease, and stroke) have complex pathogenesis and affect a substantial proportion of the population; yet, available treatments have poor or limited efficacy, and the patients have a poor prognosis, with high morbidity and mortality. Dihydromyricetin (DHM), a flavonoid compound extracted from plants, has received widespread attention in recent years because of its diverse pharmacological effects. and studies have revealed its substantial antioxidant, anti-inflammatory, and neuroprotective properties, making it a promising candidate for the treatment of central nervous system disorders through multiple mechanisms and pleiotropic effects. Therefore, there is an urgent need to develop novel therapeutic strategies. DHM is an attractive candidate for the management of neurological disorders, but there is a lack of a systematic summary of the knowledge status and gaps. Therefore, to address this challenge, we systematically reviewed the pharmacological mechanisms of DHM in central nervous system disorders and its potential applications in related conditions. We analyzed the therapeutic potential and current challenges of DHM to provide a reference for its development and application as a novel therapeutic agent. The review suggests that DHM possesses significant potential for the management of neurological disorders.

摘要

神经疾病(如阿尔茨海默病、帕金森病和中风)具有复杂的发病机制,影响着相当一部分人群;然而,现有的治疗方法疗效不佳或有限,患者预后较差,发病率和死亡率较高。二氢杨梅素(DHM)是一种从植物中提取的黄酮类化合物,近年来因其多样的药理作用而受到广泛关注。多项研究揭示了其强大的抗氧化、抗炎和神经保护特性,使其成为通过多种机制和多效性作用治疗中枢神经系统疾病的有前景的候选药物。因此,迫切需要开发新的治疗策略。DHM是治疗神经疾病的一个有吸引力的候选药物,但缺乏对其知识现状和差距的系统总结。因此,为应对这一挑战,我们系统地综述了DHM在中枢神经系统疾病中的药理机制及其在相关病症中的潜在应用。我们分析了DHM的治疗潜力和当前面临的挑战,为其作为新型治疗药物的开发和应用提供参考。该综述表明,DHM在治疗神经疾病方面具有巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fb/12308142/1a376dae993a/fphar-16-1618623-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fb/12308142/7ea4a066b20e/fphar-16-1618623-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fb/12308142/883538c166fb/fphar-16-1618623-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fb/12308142/d3bd03854d25/fphar-16-1618623-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fb/12308142/1a376dae993a/fphar-16-1618623-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fb/12308142/7ea4a066b20e/fphar-16-1618623-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fb/12308142/883538c166fb/fphar-16-1618623-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fb/12308142/d3bd03854d25/fphar-16-1618623-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fb/12308142/1a376dae993a/fphar-16-1618623-g004.jpg

相似文献

1
Pharmacological mechanisms and potential clinical applications of Dihydromyricetin in neurological disorders.二氢杨梅素在神经疾病中的药理机制及潜在临床应用
Front Pharmacol. 2025 Jul 16;16:1618623. doi: 10.3389/fphar.2025.1618623. eCollection 2025.
2
Management of faecal incontinence and constipation in adults with central neurological diseases.成人中枢神经系统疾病患者粪便失禁和便秘的管理
Cochrane Database Syst Rev. 2014 Jan 13;2014(1):CD002115. doi: 10.1002/14651858.CD002115.pub5.
3
Management of faecal incontinence and constipation in adults with central neurological diseases.成人中枢神经系统疾病患者大便失禁和便秘的管理
Cochrane Database Syst Rev. 2013 Dec 18(12):CD002115. doi: 10.1002/14651858.CD002115.pub4.
4
Conservative, physical and surgical interventions for managing faecal incontinence and constipation in adults with central neurological diseases.保守治疗、物理治疗和手术干预用于治疗伴有中枢神经系统疾病的成年人的粪便失禁和便秘。
Cochrane Database Syst Rev. 2024 Oct 29;10(10):CD002115. doi: 10.1002/14651858.CD002115.pub6.
5
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
Selegiline for Alzheimer's disease.司来吉兰用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2003(1):CD000442. doi: 10.1002/14651858.CD000442.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
8
Pain management for women in labour: an overview of systematic reviews.分娩期女性的疼痛管理:系统评价综述
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD009234. doi: 10.1002/14651858.CD009234.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Pharmacological treatment of children with gastro-oesophageal reflux.胃食管反流患儿的药物治疗
Cochrane Database Syst Rev. 2014 Nov 24;2014(11):CD008550. doi: 10.1002/14651858.CD008550.pub2.

本文引用的文献

1
Dihydromyricetin Alleviated Acetaminophen-Induced Acute Kidney Injury via Nrf2-Dependent Anti-Oxidative and Anti-Inflammatory Effects.二氢杨梅素通过Nrf2依赖性抗氧化和抗炎作用减轻对乙酰氨基酚诱导的急性肾损伤。
Int J Mol Sci. 2025 Mar 6;26(5):2365. doi: 10.3390/ijms26052365.
2
Dihydromyricetin attenuates intervertebral disc degeneration by inhibiting NLRP3 inflammasome activation via the Keap1/Nrf2/HO-1 pathway.二氢杨梅素通过Keap1/Nrf2/HO-1途径抑制NLRP3炎性小体激活来减轻椎间盘退变。
Eur J Pharmacol. 2025 Jul 5;998:177501. doi: 10.1016/j.ejphar.2025.177501. Epub 2025 Mar 8.
3
Comparation of brain-targeting chitosan/sodium tripolyphosphate and ovalbumin/sodium carboxymethylcellulose nanoparticles on dihydromyricetin delivery and cognitive impairment in obesity-related Alzheimer's disease.
脑靶向壳聚糖/三聚磷酸钠和卵清蛋白/羧甲基纤维素钠纳米粒在二氢杨梅素递送及肥胖相关阿尔茨海默病认知障碍中的比较
Int J Biol Macromol. 2025 May;306(Pt 2):141517. doi: 10.1016/j.ijbiomac.2025.141517. Epub 2025 Feb 26.
4
Dihydromyricetin: an emerging compound with comprehensive effects on multiple systems.二氢杨梅素:一种对多个系统具有综合作用的新兴化合物。
Front Pharmacol. 2025 Jan 3;15:1488003. doi: 10.3389/fphar.2024.1488003. eCollection 2024.
5
Dihydromyricetin/montmorillonite intercalation compounds ameliorates DSS-induced colitis: Role of intestinal epithelial barrier, NLRP3 inflammasome pathway and gut microbiota.二氢杨梅素/蒙脱石插层化合物改善葡聚糖硫酸钠诱导的结肠炎:肠道上皮屏障、NLRP3炎性小体途径和肠道微生物群的作用
Int J Pharm. 2025 Feb 10;670:125155. doi: 10.1016/j.ijpharm.2024.125155. Epub 2024 Dec 31.
6
Apoptosis: A Comprehensive Overview of Signaling Pathways, Morphological Changes, and Physiological Significance and Therapeutic Implications.细胞凋亡:信号通路、形态变化、生理意义及治疗意义的全面概述。
Cells. 2024 Nov 6;13(22):1838. doi: 10.3390/cells13221838.
7
Nanocochleates as novel delivery vehicles for enhancement of water solubility, stability and controlled release of dihydromyricetin in gastrointestinal tract.纳米耳蜗作为一种新型给药载体,可提高二氢杨梅素在胃肠道中的水溶性、稳定性和控制释放。
Food Res Int. 2024 Dec;197(Pt 1):115174. doi: 10.1016/j.foodres.2024.115174. Epub 2024 Sep 29.
8
Dihydromyricetin protects sevoflurane-induced mitochondrial dysfunction in HT22 hippocampal cells.二氢杨梅素对七氟醚诱导的 HT22 海马细胞线粒体功能障碍的保护作用。
Clin Exp Pharmacol Physiol. 2024 Sep;51(9):e13912. doi: 10.1111/1440-1681.13912.
9
profiling and molecular dynamics simulation studies of berberine loaded MCM-41 mesoporous silica nanoparticles to prevent neuronal apoptosis.负载黄连素的MCM-41介孔二氧化硅纳米颗粒预防神经元凋亡的分析及分子动力学模拟研究
Nanoscale Adv. 2024 Apr 4;6(9):2469-2486. doi: 10.1039/d3na01142a. eCollection 2024 Apr 30.
10
NF-κB as an Inducible Regulator of Inflammation in the Central Nervous System.NF-κB 作为中枢神经系统炎症的诱导调节因子。
Cells. 2024 Mar 11;13(6):485. doi: 10.3390/cells13060485.